Study Summary
This trial will study whether time-restricted eating can improve metabolic health in postmenopausal women.
- Metabolic Syndrome
- Postmenopausal Syndrome
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: 18 weeks (baseline and post-intervention)
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control
1 of 2
Time-Restricted Feeding (TRF) Group
1 of 2
Active Control
Experimental Treatment
164 Total Participants · 2 Treatment Groups
Primary Treatment: Time-Restricted Feeding (TRF) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 45 - 65 · Female Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Who has been approved to participate in this medical experiment?
"Patients with metabolic syndrome, aged between 45 and 65 years old, who fulfill the following criteria - sedentary lifestyle, prediabetes or having at least two features of metabolic syndrome (if applicable postmenopausal women) will be accepted into this clinical trial totalling 164 participants." - Anonymous Online Contributor
Is this trial actively searching for new participants?
"Affirmative. According to data posted on clinicaltrials.gov, this medical trial is actively accepting participants and was first made available online on October 19th 2021. 164 volunteers are needed from a single test site for the study's completion." - Anonymous Online Contributor
Is this investigation recruiting participants aged 30 and over?
"This medical trial seeks patients who are between the ages of 45 and 65. Separately, there are 10 studies dedicated to minors and 111 for those surpassing retirement age." - Anonymous Online Contributor
What key insights are investigators hoping to gain from this clinical experiment?
"The main focus of this 18-week experiment is to observe shifts in Triglyceride levels. Secondary indices, such as Sleep Fragmentation Index (as measured by actigraphy), Hemoglobin A1c content, and C-Reactive Protein concentrations will also be closely monitored." - Anonymous Online Contributor
What is the maximum participant capacity for this experiment?
"Affirmative. The information published on clinicaltrials.gov reveals that this medical study is currently recruiting participants, with the original posting date being October 19th 2021 and most recent update recorded as November 15th 2022. 164 patients are needed to be enrolled from a single site." - Anonymous Online Contributor